FDA Inspection
Balkanpharma Dupnitsa ADBalkanpharma Dupnitsa AD – FDA Inspection, Sep 29, 2023
Record Details
This FDA Inspection record concerns Balkanpharma Dupnitsa AD, with an inspection on September 29, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0617b475-59cf-4eb8-b3df-7c4fba341ed6
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1222624
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Balkanpharma Dupnitsa AD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 8, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 7, 2017 | Not classified | Office of Inspections and Investigations | |
| August 28, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Balkanpharma Dupnitsa AD
- FDA Inspection 1140148 - 2019-03-01
- FDA Inspection 1057710 - 2018-06-08
- FDA Inspection 1012588 - 2017-04-07
- FDA Inspection 945384 - 2015-08-28
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.